Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. EBITDA 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual/quarterly ebitda history and growth rate from 2015 to 2022. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Corbus Pharmaceuticals Holdings, Inc. ebitda for the quarter ending March 31, 2022 was -8.3 M, a 45.04% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. ebitda for the twelve months ending March 31, 2022 was -95.1 M, a 20.30% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual ebitda for 2022 was -39.1 M, a 28.95% decrease from 2021.
- Corbus Pharmaceuticals Holdings, Inc. annual ebitda for 2021 was -55.0 M, a 54.81% decrease from 2020.
- Corbus Pharmaceuticals Holdings, Inc. annual ebitda for 2020 was -121.7 M, a 59.35% increase from 2019.
- Corbus Pharmaceuticals Holdings, Inc. annual ebitda for 2019 was -76.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corbus Pharmaceuticals Holdings, Inc. EBITDA — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's ebitda history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s ebitda by year and by quarter, including the growth rate.